Clinical Trial Update: Prevention of Left Ventricular Dysfunction During Chemotherapy [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update focusing on preventing left ventricular dysfunction during chemotherapy in patients with hematologic cancers.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia
• Acute Myeloid Leukemia
• Lymphoblastic Lymphoma
• Lymphoid Neoplasm
• Lymphoma
• Multiple Myeloma

Snippet

Sponsor: Hospital Clinic of Barcelona | Conditions: Acute Myeloid Leukemia, Precursor-cell Lymphoblastic Leukemia-Lymphoma | Phase 3 | Status: COMPLETED